Targeting βiii-Tubulin and the roots of science: An interview with Richard F. Ludueña
Open Access Government · 16.04.2026 · 50 (1) · 188-189
DOI: 10.56367/oag-050-12584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access Government, erschienen am 16.04.2026. Verfasst von Richard F Ludueña.
Abstract (Originalsprache)
Targeting βiii-Tubulin and the roots of science: An interview with Richard F. Ludueña Professor Emeritus Richard F. Ludueña discusses his novel theoretical framework for cancer chemotherapy, utilising CRISPR-Cas9 to target specific tubulin isotypes. He also explores his current research into the historical intersection of science and religion in the ancient Mesopotamian centres of Harran and Edessa.
Zitieren
APA
Ludueña, R. F. (2026). Targeting βiii-Tubulin and the roots of science: An interview with Richard F. Ludueña. Open Access Government, 50(1), 188-189. https://doi.org/10.56367/oag-050-12584
Vancouver
Ludueña RF. Targeting βiii-Tubulin and the roots of science: An interview with Richard F. Ludueña. Open Access Government. 2026;50(1):188-189. doi:10.56367/oag-050-12584
BibTeX
@article{Luduea2026,
author = {Ludueña, Richard F},
title = {Targeting βiii-Tubulin and the roots of science: An interview with Richard F. Ludueña},
journal = {Open Access Government},
year = {2026},
volume = {50},
number = {1},
pages = {188--189},
doi = {10.56367/oag-050-12584}
}
EUVIMED